ZA968773B - Nitroflavonoids - Google Patents

Nitroflavonoids

Info

Publication number
ZA968773B
ZA968773B ZA968773A ZA968773A ZA968773B ZA 968773 B ZA968773 B ZA 968773B ZA 968773 A ZA968773 A ZA 968773A ZA 968773 A ZA968773 A ZA 968773A ZA 968773 B ZA968773 B ZA 968773B
Authority
ZA
South Africa
Prior art keywords
nitroflavonoids
Prior art date
Application number
ZA968773A
Other languages
English (en)
Inventor
Alejandro Constantino Paladini
Jorge Horacio Medina
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Publication of ZA968773B publication Critical patent/ZA968773B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
ZA968773A 1995-10-17 1996-10-17 Nitroflavonoids ZA968773B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9521184.3A GB9521184D0 (en) 1995-10-17 1995-10-17 Flavonoids

Publications (1)

Publication Number Publication Date
ZA968773B true ZA968773B (en) 1997-05-27

Family

ID=10782385

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA968773A ZA968773B (en) 1995-10-17 1996-10-17 Nitroflavonoids

Country Status (9)

Country Link
US (1) US6080780A (es)
EP (1) EP0857066B1 (es)
JP (1) JP4745468B2 (es)
AU (1) AU7310896A (es)
DE (1) DE69621447T2 (es)
ES (1) ES2177811T3 (es)
GB (1) GB9521184D0 (es)
WO (1) WO1997014414A1 (es)
ZA (1) ZA968773B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9707013D0 (en) * 1997-04-07 1997-05-28 Univ Strathclyde Halo and/or nitro-substituted flavonoids
US7183314B1 (en) 2000-07-21 2007-02-27 Naturon Limited Compound for treatment of anxiety and methods of preparation and use thereof
RU2209062C1 (ru) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Вещество, обладающее седативным действием
GB0216371D0 (en) * 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
US20050080024A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20050080021A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
US20040033480A1 (en) * 2002-08-15 2004-02-19 Wong Norman C.W. Use of resveratrol to regulate expression of apolipoprotein A1
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids
US20090221568A1 (en) * 2005-11-04 2009-09-03 Jared Shaw Synthesis of Inhibitors of FtsZ
EP2478901A3 (en) * 2007-02-14 2012-11-14 Mars Incorporated Neurogenic compounds
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
KR20190022085A (ko) * 2017-08-25 2019-03-06 건국대학교 글로컬산학협력단 타마리세틴을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317071D0 (en) * 1993-08-17 1993-09-29 Univ Strathclyde Flavonoids

Also Published As

Publication number Publication date
EP0857066A1 (en) 1998-08-12
ES2177811T3 (es) 2002-12-16
GB9521184D0 (en) 1995-12-20
WO1997014414A1 (en) 1997-04-24
JP4745468B2 (ja) 2011-08-10
US6080780A (en) 2000-06-27
AU7310896A (en) 1997-05-07
EP0857066B1 (en) 2002-05-29
DE69621447D1 (de) 2002-07-04
JP2000505055A (ja) 2000-04-25
DE69621447T2 (de) 2003-05-08

Similar Documents

Publication Publication Date Title
DE69513693D1 (en) Positions-servo-system
DE59607964D1 (en) Oxymethoxy-3-aryl-pyron-derivate
DE69608292D1 (en) Audio-synthesizer
DE69606427D1 (en) Hydroformylierungsverfahren
DE59607241D1 (en) Endotracheal-tubus
DE69611623D1 (en) Polyurethanelastomere
DE69516545D1 (en) Polyacetalharzzusammensetzung
DE69610843D1 (en) Hydroformylierungsverfahren
DE59610991D1 (en) Cyclopeptidderivate
ZA968773B (en) Nitroflavonoids
DE59608164D1 (en) Cyclohexenonoximether-metallsalze
DE59602888D1 (en) Breitstreckaggregat
DE59605001D1 (en) Luftreinigungsgerät
DE59602030D1 (en) Zellige polyurethan-elastomere
DE59602283D1 (en) Inchbremseinrichtung
DE69610077D1 (en) Sesquiterpenverbindungen
DE69612563D1 (en) Hydroformylierungsverfahren
DE59505396D1 (en) Handhobelmaschine
DE69611833D1 (en) Carbonylierungsreaktionen
AP9600802A0 (en) Libricant
DE59604506D1 (en) Rückkühlsystem
DE59600830D1 (en) Breitstrahldüse
DE59604913D1 (en) Carbonylverbindungen
AU1105P (en) DALESE Metrosideros excelsus
DE59609059D1 (en) Conventional-direct-glazing